ClinConnect ClinConnect Logo
Search / Trial NCT04812093

Spectroscopic Evaluation of Middle Ear Infection

Launched by UNIVERSITY OF CALIFORNIA, IRVINE · Mar 19, 2021

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

Middle Ear Infection

ClinConnect Summary

This clinical trial, titled "Spectroscopic Evaluation of Middle Ear Infection," is looking at a new way to diagnose middle ear infections, which are very common in young children. These infections can cause pain and may lead to surgery if they occur frequently. Currently, doctors often check the ear by looking at the eardrum with a special tool called an otoscope, but this method can sometimes be inaccurate. In this study, researchers want to use a special light technique to get a clearer picture of the eardrum and the middle ear, which may help improve how these infections are diagnosed.

To participate in this trial, you need to be either a child or an adult who has been diagnosed with a middle ear infection and is scheduled for surgery. Unfortunately, pregnant women and individuals who cannot provide consent due to cognitive issues cannot take part. If you join the study, you can expect to have your ear examined using this new light technique, which could lead to better understanding and treatment of your condition. The trial is currently recruiting participants of all ages, from newborns to older adults.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Male/ female at all age- newborn to adult.
  • 2. Non- pregnant woman.
  • 3. Diagnose of middle ear infection and plan for surgery procedure.
  • Exclusion Criteria:
  • 1. Pregnant woman
  • 2. Incompetent adults (i.e. individuals with cognitive impairment)
  • 3. No diagnose of middle ear infection and no plan for surgery procedure.
  • 4. Adults with cognitive impairment and children of parents that are cognitively impaired and thus are unable to consent will be excluded from the study.

About University Of California, Irvine

The University of California, Irvine (UCI) is a leading research institution renowned for its commitment to advancing health and medical knowledge through innovative clinical trials. With a robust infrastructure for clinical research, UCI fosters interdisciplinary collaboration among its esteemed faculty and researchers, aiming to translate scientific discoveries into effective therapeutic solutions. The university prioritizes ethical standards and participant safety while addressing critical healthcare challenges across various fields, including cancer, neurology, and public health. UCI's dedication to excellence in research and education positions it as a pivotal contributor to the advancement of clinical science and patient care.

Locations

Orange, California, United States

Orange, California, United States

Patients applied

0 patients applied

Trial Officials

Elliot Botvinick

Principal Investigator

University of Calfornia Irvine

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials